NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights Portfolio News / By Karina Tin November 2, 2023 NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights Read More »
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial Portfolio News / By Karina Tin November 1, 2023 Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial Read More »
